Skip to content
Medical Health Aged Care

GPs call for better ADHD care in Tasmania: ‘The current system serves no one’

Royal Australian College of GPs 2 mins read

The Royal Australian College of GPs will today urge Tasmanian politicians to overhaul how ADHD is assessed and treated to allow more GPs to support patients in areas of high need.

At a hearing of the House of Assembly Inquiry into the assessment and treatment of ADHD and support services on Friday 18 October, Tasmanian GP Dr Tim Jones will call for greater support to help GPs assess and treat patients with ADHD alongside a wider team including paediatricians and psychiatrists.

Dr Jones, who is Chair of the RACGP Specific Interests Child and Young Person’s Health group, said the status quo in the state is letting people down.

“The current system serves no one," he said.

“Patients, both children and adults, aren’t getting timely or affordable care. GPs are seeing their patients struggle. Families shouldn't have to wait so long to receive the care and treatment they need.

“We need to embrace team-based care, bridge the rural divide, and look at innovative models to deliver better care now and into the future.

“We also need to firm up links with our education system so we can support them in their pivotal role in developing the next generation of medical professionals.”

Dr Jones will speak in support of the RACGP’s submission to the inquiry.

Alongside calls for models that support effective GP led diagnosis for patients with ADHD, the RACGP recommends making multidisciplinary models of care standard and introducing further support for shared-care arrangements.

This includes supporting GPs to prescribe stimulant medication for stable patients with ADHD, so patients don’t require frequent and costly specialist reviews.

RACGP Tasmania Chair Dr Toby Gardner said Tasmania should not fall further behind progress in other states.  

“There are simply too many patients with ADHD who are still not getting the support they need in a timely way in Tasmania, particularly in rural and regional areas,” he said.

"It is essential for the Tasmanian Government to cut red tape and allow GPs to play a more active role supporting our patients through assessment and management of ADHD, in a coordinated approach from a team including psychiatrists, paediatricians, and allied health professionals.

“This measure would reduce the burden on specialist services, cut patient costs and improve access for Tasmanian patients.

“It is time to move towards a nationally consistent approach that helps adults and children living with ADHD access individualised support via the health professional that knows them best – their GP.”

~ENDS


About us:

The Royal Australian College of General Practitioners (RACGP) is the peak representative organisation for general practice, the backbone of Australia’s health system. We set the standards for general practice, facilitate lifelong learning for GPs, connect the general practice community, and advocate for better health and wellbeing for all Australians.

Visit www.racgp.org.au. To unsubscribe from RACGP media releases, click here.


Contact details:

John Ronan
Media Adviser

Ally Francis
Media Adviser

Stuart Winthrope
Media Officer

Contact: 03 8699 0992media@racgp.org.au

Follow us on Twitter: @RACGP and Facebook.

Media

More from this category

  • Medical Health Aged Care, Research Development
  • 17/02/2025
  • 15:07
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG Announces Keynote Speaker for 2025 Annual Scientific Meeting: A/Professor Carien Creutzberg

The Australia New ZealandGynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the…

  • Contains:
  • Medical Health Aged Care
  • 17/02/2025
  • 11:51
Monash University

Monash Expert: Landmark approval of weight loss drug for heart disease

For the first time in Australia, a weight loss drug has been approved to also treat cardiovascular disease in overweight and obese patients. The Therapeutic Goods Administration (TGA) has granted approval for semaglutide 2.4 mg (sold as Wegovy) to be used as a complementary therapy for reducing major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction (heart attack), or non-fatal stroke. The approval follows findings from the SELECT trial, an international study involving more than 17,000 participants across 41 countries, including Australia. Results published in late 2023 showed that Wegovy reduced cardiovascular events by 20 percent in people…

  • Medical Health Aged Care
  • 17/02/2025
  • 10:11
Smith & Nephew UK Ltd

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair*After anchor insertionSmith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of a comprehensive foot & ankle repair portfolio in Australia and New Zealand (ANZ) with proprietary adjustable tensioning technology. The ULTRABRIDGE◊ Adjustable Achilles Reconstruction and ULTRABRACE◊ Adjustable Ankle Instability Techniques are changing the way foot & ankle surgeons perform these repairs by allowing them to refine and optimise suture tension after anchor insertion.The ability to adjust tension for specific patients allows the surgeon to give the precise amount of range-of-motion…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.